Showing results (161-170 of 179) with videos related to
Sort By:
Pageof 18
Genome Medicine|May 31, 2022
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesotheliomaJenette Creaney, Ann-Marie Patch, Venkateswar Addala, et al.BMJ Open|September 3, 2020
Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesotheliomaEric Lim, Liz Darlison, John Edwards, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 26, 2020
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesotheliomaIsabelle Opitz, Arnaud Scherpereel, Thierry Berghmans, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2019
Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning MeetingRitu R Gill, Anne S Tsao, Hedy L Kindler, et al.Nature Communications|March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.Nature Communications|July 21, 2025
Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trialDean A Fennell, Kayleigh Hill, Min Zhang, et al.Cancer Discovery|June 19, 2025
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemiaShellaina J V Gordon, Florian Perner, Laura MacPherson, et al.ESMO Open|July 18, 2022
Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panelsP Ramarao-Milne, O Kondrashova, A-M Patch, et al.Nature Communications|June 22, 2019
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemiaCharles C Bell, Katie A Fennell, Yih-Chih Chan, et al.Cell|November 8, 2025
Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk predictionJames R M Black, Takahiro Karasaki, Charles W Abbott, et al.Pageof 18